CSPC Pharmaceutical Group Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CVGU.F | 300181.SZ | 002422.SZ | CUP.F | 0570.HK | SMZ1.F | |
|---|---|---|---|---|---|---|
| Market cap | 9.92B | 9.13B | 68.01B | 62.53B | 5.87B | 10.15B |
| P/E (TTM) | 10.9 | 14.3 | 37.2 | 23.9 | — | 28.5 |
| Forward P/E | — | 13.6 | 28.5 | 0.3 | 7.6 | — |
| Price/book | 2.0 | 2.7 | 2.8 | 5.5 | 0.3 | 2.3 |
| Dividend yield | 4.21% | 5.44% | 1.39% | 2.04% | — | 2.64% |
| 1-year change | +4.85% | −29.42% | +23.44% | −8.53% | −52.30% | −27.04% |
| Today | +0.58% | +1.17% | −0.02% | +1.82% | +2.19% | +3.45% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All CVGU.F news ›CSPC Pharmaceutical Says Phase I Clinical Trial Of SYH2083 Eye Drops Initiated In China
TradingView CSPC Pharmaceutical Says Phase I Clinical Trial Of SYH2083 Eye Drops Initiated In China
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com3
-
tradingview.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.